Loading...
Loading...
Browse all stories on DeepNewz
VisitNext major AI-designed protein application in drug development by end of 2025?
Cancer treatment • 25%
Viral infections • 25%
Bacterial infections • 25%
Autoimmune diseases • 25%
Scientific publications or official announcements from research institutions
AI-Designed Proteins Neutralize Snake Venom Toxins, Achieving 80-100% Survival Rates in Mice Tests on January 15 by David Baker
Jan 15, 2025, 02:00 PM
Researchers have successfully utilized artificial intelligence (AI) to design proteins that can neutralize toxins from snake venom, a breakthrough that could lead to the development of more effective and safer antivenoms. A study published on January 15 in the journal Nature, led by Nobel Laureate David Baker's team, demonstrated that these AI-designed proteins achieved survival rates of 80-100% in tests conducted on mice. This innovative approach not only offers a faster and cheaper method for creating antivenoms but also addresses the urgent need for improved treatments for snakebite envenoming, which poses a significant public health challenge globally. The research highlights the potential of generative AI in drug development, particularly in the design of therapeutic proteins against neglected tropical diseases.
View original story
Pfizer • 25%
Other • 25%
Johnson & Johnson • 25%
Merck • 25%
Neurological disorders • 25%
Infectious diseases • 25%
Other • 25%
Cancer • 25%
Drug Discovery • 25%
Other • 25%
Healthcare Delivery Improvement • 25%
Clinical Trials Optimization • 25%
Neurological treatment • 25%
Cardiovascular treatment • 25%
Cancer treatment • 25%
Other • 25%
Novel biologics • 25%
Biparatopic antibodies • 25%
Other • 25%
New molecular entities • 25%
More than 30% • 25%
Less than 10% • 25%
10% to 20% • 25%
20% to 30% • 25%
Southeast Asia • 25%
South America • 25%
Sub-Saharan Africa • 25%
Other • 25%